Viewing Study NCT01686633


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-02-08 @ 3:28 PM
Study NCT ID: NCT01686633
Status: COMPLETED
Last Update Posted: 2018-01-24
First Post: 2012-09-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None asthma View
None pharmacogenetics View
None adult View
None vilanterol View
None adolescents View
None fluticasone furoate View